Aarti Pharmalabs Shareholding Pattern
- Market cap
- ₹8,658 crore
- P/E
- 40.6
- P/B
- 4.08
- ROE
- 8.5%
- Dividend yield
- 0.21%
As of 30-JUN-2026, promoters held 42.86% of Aarti Pharmalabs (-0.22 pp from 31-MAR-2026), foreign institutional investors 8.17%, domestic institutions 7.22%, the government 0.01% and the public 41.74%.
Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 7 October 2026. How this data is compiled.
Aarti Pharmalabs shareholding pattern — frequently asked questions
What is the promoter holding in Aarti Pharmalabs?
Promoters held 42.86% of Aarti Pharmalabs as of 30-JUN-2026, down 0.22 pp from 43.08% in 31-MAR-2026.
How much do FIIs hold in Aarti Pharmalabs?
Foreign institutional investors held 8.17% of Aarti Pharmalabs as of 30-JUN-2026, a change of -0.22 pp from the previous quarter.
How much do domestic institutions hold in Aarti Pharmalabs?
Domestic institutional investors, including mutual funds and insurers, held 7.22% of Aarti Pharmalabs as of 30-JUN-2026 (-0.19 pp from the previous quarter).
Who owns Aarti Pharmalabs?
As of 30-JUN-2026, Aarti Pharmalabs' shareholders were promoters (42.86%), foreign institutional investors 8.17%, domestic institutions 7.22%, the government 0.01% and the public 41.74%, as filed with the stock exchanges.
Same Data For Peers
Trade Aarti Pharmalabs With ATS
Track AARTIPHARM live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.